Ulf Bremberg is CEO and co-founder of Osmond Labs and board member of Osmond Foundation. Ulf Bremberg has a 19-year background with industrial pharmaceutical development in pharma/biotech and has founded six companies. Earlier positions include Chief Scientific Officer at Beactica Tx, head of Lead Identification Facility at the national infrastructure SciLifeLab Drug Discovery & Development Platform, CEO of OncoTargeting AB, Chemistry Team Leader and Medicinal Chemist at Biovitrum and Pharmacia. Ulf Bremberg did his post-doc at the Scripps Research Institute and holds a Ph.D. in Organic Chemistry from KTH Royal Institute of Technology.